Salt Reduction Population Risk Reduction Estimator

Salt Reduction Population Risk Reduction Estimator: Explanation and Clinical Context This estimator quantifies the potential impact of reducing average daily salt consumption on population-level blood pressure and cardiovascular risk. Excessive sodium intake is a major modifiable determinant of hypertension, which in turn is a leading cause of stroke, ischemic heart disease, and chronic kidney disease. Meta-analyses have consistently demonstrated that for every 1 gram per day reduction in salt intake, mean systolic blood pressure decreases by approximately 1 to 1.5 mmHg in adults.

Population-level modeling, such as that conducted by the World Health Organization and Global Burden of Disease collaborators, indicates that achieving the WHO-recommended target of less than 5 g/day of salt intake could prevent millions of cardiovascular deaths globally each year. The tool provided here applies these relationships in a simplified quantitative form, using established meta-regression coefficients linking sodium reduction, blood pressure lowering, and consequent risk reduction for cardiovascular events. Clinical Significance: Even modest reductions in average salt intake across a population produce substantial health benefits.

A 2 mmHg fall in systolic blood pressure reduces ischemic heart disease mortality by approximately 7% and stroke mortality by about 10%. This model helps policymakers and clinicians estimate the scale of benefit associated with dietary sodium reduction programs, public health initiatives, or food industry reformulations.